Issue navigation
Volume 184, Issue 4, Apr 2021
Commentary
Adult growth hormone deficiency guidelines: more difficult than it seems to incorporate into clinical practice universally
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages C5–C7, https://doi.org/10.1530/EJE-20-1455
Review
MANAGEMENT OF ENDOCRINE DISEASE: Glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages R111–R122, https://doi.org/10.1530/EJE-20-1199
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages R123–R135, https://doi.org/10.1530/EJE-20-1284
DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages R137–R149, https://doi.org/10.1530/EJE-20-0468
DIAGNOSIS OF ENDOCRINE DISEASE: Diagnosing and classifying diabetes in diseases of the exocrine pancreas
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages R151–R163, https://doi.org/10.1530/EJE-20-0974
Clinical Study
Semen quality and testicular adrenal rest tumour development in 46,XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 487–501, https://doi.org/10.1530/EJE-20-1154
NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 503–511, https://doi.org/10.1530/EJE-20-1345
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 513–520, https://doi.org/10.1530/EJE-20-1064
MCM7 as a marker of postsurgical progression in non-functioning pituitary adenomas
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 521–531, https://doi.org/10.1530/EJE-20-1086
White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 533–541, https://doi.org/10.1530/EJE-20-1130
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 543–552, https://doi.org/10.1530/EJE-20-1445
International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 553–563, https://doi.org/10.1530/EJE-20-1249
Imaging cerebral microbleeds in Cushing's disease evaluated by quantitative susceptibility mapping: an observational cross-sectional study
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 565–574, https://doi.org/10.1530/EJE-20-1139
Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy(Details of the Diabetes Study Group of ISPED is given in the Acknowledgements section)
(Details of the Diabetes Study Group of ISPED is given in the Acknowledgements section)
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 575–585, https://doi.org/10.1530/EJE-20-1030
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 587–596, https://doi.org/10.1530/EJE-20-1240
Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 597–606, https://doi.org/10.1530/EJE-20-1396
The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 607–615, https://doi.org/10.1530/EJE-20-1268
Recovery of hypothalamus–pituitary–gonadal dysfunction after the treatment of suprasellar germ cell tumors
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 617–625, https://doi.org/10.1530/EJE-20-1310
Retraction
Retraction: Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Page Z1, https://doi.org/10.1530/EJE-20-0857z
